Analyst Richard Law works at CREDIT SUISSE and is covering the the Healthcare sector with 73 price targets and ratings documented since 2022 spanning on 10 stocks.
Richard Law's average stock forecast success ratio is 21.67% with an average time for price targets to be met of 26 days.
Most recent stock forecast was given on KYMR, Kymera Therapeutics Inc. at 05-Jun-2023.
Analyst best performing recommendations are on FIXX.
The best stock recommendation documented was for FIXX at 5/17/2022. The price target of $2.1 was fulfilled within 21 days with a profit of $0.59 (39.07%) receiving and performance score of 18.61.
Average potential price target upside
Currently, out of the existing stock ratings of Richard Law - 2 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
35
$10.99 (45.77%)
36
27 days ago
3/7 (42.86%)
$19 (50.01%)
18
Buy
72
$47.99 (199.88%)
82
1 months ago
0/6 (0%)
$32.42 (67.95%)
Buy
95
$70.99 (295.67%)
95
1 months ago
2/6 (33.33%)
$45.26 (127.73%)
99
Buy
90
$65.99 (274.84%)
90
1 months ago
2/5 (40%)
$34.84 (109.12%)
129
Buy
61
$36.99 (154.06%)
61
1 months ago
0/5 (0%)
$34.43 (89.12%)
